A Study of Cognitive Health in Survivors of Prostate Cancer

The purpose of this study is to collect information that may help the researchers understand the relationship between prostate cancer survivors' experiences of cancer-related cognitive dysfunction (CRCD) and their other conditions (co-morbid factors), including anxiety, depression, and insomnia. The researchers will also find out how additional things may contribute to CRCD, including social factors, the characteristics of participants' prostate cancer, and the type of cancer treatment or other medications they received.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Prostate Cancer Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Male Urogenital Diseases Neoplasms Neoplasms by Site Prostatic Diseases Prostatic Neoplasms Survivorship Urogenital Diseases Urogenital Neoplasms

Age range

18 year and older

Sex eligibility

Male

Study type

Observational

Primary location

Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

English-speaking
Age 18 years or older
History of histologically documented PC of any stage
No evidence of PC Disease

Exclusion criteria

<1 month since completion of surgery, radiation, chemotherapy, or ADT
Diagnosis of Alzheimer's disease, vascular dementia, Parkinson disease, or other organic brain disorder
Score >10 indicative of dementia on Blessed Orientation Memory Concentration

Treatment and study plan

PROMIS-SF v2.0 -Cognitive Function 8a

Behavioral

Patient-Reported Outcomes (PROs)

Primary outcomes

number of participants with co-morbid symptoms

Time frame: 1 year

All participants will be evaluable as long as they have completed the PROMIS-SF v2.0 - Cognitive Function 8a.

Sponsors and collaborators

Lead sponsor

Memorial Sloan Kettering Cancer Center

Other

Registry information

Official study title

Prostate Cancer Survivorship and Cognitive Health (PRO-HEALTH)

Important dates

Study start: 2022
Primary completion: 2026
Study completion: 2026
First posted: Sep 15, 2022
Registry last updated: Oct 9, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, Not Recruiting